Cara Therapeutics (CARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CARA | AMGN | GILD | BIIB | CELG |
| Company | Cara Therapeutics | Amgen Inc | Gilead Sciences Inc | Biogen Inc | Celgene Corp |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.2994 | 335.15 | 83.26 | 200.01 | 108.01 |
| High | 0.3100 | 338.19 | 83.76 | 200.37 | 108.59 |
| Low | 0.2901 | 334.27 | 82.75 | 196.97 | 107.27 |
| Last | 0.2959 | 336.83 | 83.15 | 197.87 | 108.24 |
| Change | -0.0128 | +0.88 | -0.75 | -3.57 | +0.11 |
| % Change | -4.15% | +0.26% | -0.89% | -1.77% | +0.10% |
| Volume | 92,691 | 1,366,118 | 4,712,286 | 470,619 | 191,230,496 |
| 20-Day Average Volume | 408,181 | 1,715,325 | 6,621,241 | 810,928 | 16,188,930 |
| Previous Close | 0.3087 | 335.95 | 83.90 | 201.44 | 108.13 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | No |
| Technicals | |||||
| 20-Day Moving Average | 0.3145 | 330.16 | 80.45 | 201.34 | 108.17 |
| 20-Day Raw Stochastic | 42.54% | 85.42% | 83.41% | 40.66% | 63.25% |
| 20-Day Relative Strength | 44.43% | 57.77% | 69.33% | 41.67% | 64.69% |
| Weighted Alpha | -69.01 | +27.16 | +17.27 | -23.39 | +46.30 |
| Today's Opinion | 100% Sell | 96% Buy | 88% Buy | 100% Sell | 100% Buy |
| Previous Opinion | 100% Sell | 96% Buy | 88% Buy | 100% Sell | 100% Buy |
| Last Month's Opinion | 88% Sell | 88% Buy | 56% Buy | 88% Sell | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +15.01% since 09/13/24 | +1.09% since 09/13/24 | +0.71% since 09/13/24 | +1.28% since 09/13/24 | -1.97% since 11/13/19 |
| Low | 0.2500 on 09/16/24 | 331.00 on 09/18/24 | 82.38 on 09/17/24 | 194.75 on 09/16/24 | 107.27 on 11/20/19 |
| High | 0.3114 on 09/19/24 | 339.00 on 09/18/24 | 84.65 on 09/19/24 | 204.18 on 09/19/24 | 110.53 on 11/14/19 |
| 1-Month | |||||
| %Chg | -10.89% since 08/20/24 | +2.29% since 08/20/24 | +11.57% since 08/20/24 | -3.58% since 08/20/24 | +5.14% since 10/18/19 |
| Low | 0.2500 on 09/16/24 | 319.00 on 09/06/24 | 74.80 on 08/21/24 | 192.25 on 09/13/24 | 102.40 on 10/21/19 |
| High | 0.3720 on 08/26/24 | 339.00 on 09/18/24 | 84.89 on 09/12/24 | 207.59 on 08/21/24 | 110.70 on 11/13/19 |
| 3-Month | |||||
| %Chg | +22.42% since 06/20/24 | +8.45% since 06/20/24 | +21.77% since 06/20/24 | -12.17% since 06/20/24 | +13.63% since 08/20/19 |
| Low | 0.2500 on 09/16/24 | 306.11 on 07/03/24 | 66.01 on 07/05/24 | 192.25 on 09/13/24 | 93.41 on 08/23/19 |
| High | 0.4100 on 07/11/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 238.00 on 07/12/24 | 110.70 on 11/13/19 |
| 6-Month | |||||
| %Chg | -66.56% since 03/20/24 | +23.09% since 03/20/24 | +12.73% since 03/20/24 | -9.18% since 03/20/24 | +14.14% since 05/20/19 |
| Low | 0.2400 on 06/20/24 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 189.44 on 04/19/24 | 89.08 on 07/23/19 |
| High | 0.9600 on 03/28/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 238.00 on 07/12/24 | 110.70 on 11/13/19 |
| Key Statistics | |||||
| Market Capitalization, $K | 16,878 | 180,215,344 | 104,527,072 | 29,329,060 | 77,035,920 |
| Shares Outstanding, K | 54,676 | 536,435 | 1,245,853 | 145,597 | 711,714 |
| Annual Sales | 20,970,000 | 28,190,000,000 | 27,116,000,000 | 9,835,600,000 | 15,281,000,000 |
| Annual Net Income | -118,510,000 | 6,717,000,000 | 5,665,000,000 | 1,161,100,000 | 4,046,000,000 |
| Last Quarter Sales | 990,000 | 8,388,000,000 | 6,954,000,000 | 2,464,900,000 | 4,520,000,000 |
| Last Quarter Net Income | -20,020,000 | 746,000,000 | 1,614,000,000 | 583,600,000 | 1,691,000,000 |
| 60-Month Beta | 0.70 | 0.61 | 0.18 | -0.06 | 1.41 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.37 on 08/14/24 | 4.97 on 08/06/24 | 2.01 on 08/08/24 | 5.28 on 08/01/24 | 2.99 on 10/31/19 |
| Latest Earnings Date | 11/11/24 | 10/29/24 | 11/05/24 | 11/13/24 | 10/31/19 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | 09/13/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.90 | 17.85 | 12.15 | 10.99 |